Abstract:Subtype-selective α1-adrenoceptor (AR) antagonists display optimum therapeutic efficacies for the treatment of benign prostatic hyperplasia (BPH). In this study, we designed and synthesized novel carbazole-arylpiperazines derivatives (1 and 2) on the basis of the proposed pharmacophore model for α1-AR antagonists. Structural properties were investigated using single-crystal X-ray diffraction analysis. Comparison of crystal structures with ligand-based pharmacophore models revealed that the two agents may possess antagonistic effects on α1D subtype. Tissue functional assay in vitro showed that compound 2 exerted strong antagonistic activity on α1B-AR (pA2 7.13) with a poor selectivity for α1A and α1D subtypes. Compound 1 exhibited enhanced antagonistic effect on α1D subtype (pA2 7.06) and excellent selectivity for α1D over α1B (α1D/α1B ratio=79.4). To illustrate the relationship between antagonistic activity and chemical structure, molecular docking studies were performed using the homology models of α1 receptors. Binding mechanism indicated that small hydrophobic substituents attached to the arylpiperazine moiety were essential for rational design of α1D-selective antagonists.

Design,synthesis and biological activities of 1-(5- t -butyl-2-benzoxazolemethyl)-4-aryloxyalkyl-piperazine as α1 adrenoceptor antagonists

Synthesis and Biological Activity of 1-(1,4-benzodioxan-2-yl-carbonyl)-4-aryloxy-alkyl-piperazine As Α_1-Adrenoceptor Antagonists

Synthesis, biological evaluation and 3D-QSAR study of 1-(1,4-benzodioxan-2-ylcaronyl)-4-aryloxyalkyl-piperazines as α1-adrenoceptor antagonists

Design, Synthesis and Biological Estimation of 1-(Benzoxazole-2-yl)piperazine and 4-(Benzoxazole-2-yl)piperidine Derivatives As Potential Α1-Ar Antagonists

Design, Synthesis And Biological Activity Study On N-[4-(Substituted Phenyl)Piperazine-1-Yl]Alkyl Amide Series As Alpha(1)-Adrenoceptor Antagonists

Design, Synthesis And 3d-Qsar Study Of 2-[N '-(2-Aryloxyethyl)Piperazinomethyl]-Benzoxazole Series As Alpha(1)-Adrenoceptor Antagonists

Searching for the Novel Lead Compounds of alpha(1)-AR Antagonists (Part I): Design, Synthesis and Bioassay of 5-Chloro-2-[4-(aryloxyalkyl)piperazin-1-yl] benzo[d]oxazole Compounds

Synthesis and Biological Activity Study on N-( 3,4- Dimethoxyphenylethyl )-4-subtituted Phenylpiperazine-1- Acetamide Series As Α1-Adrenoceptor Antagonists

Design and Synthesis of Novel Aryloxyalkyl-arylpiperazine Derivatives As Αla-Adrenoceptor Antagonists

Design and Synthesis of Novel Aryloxyalkyl-Arylpiperazine Derivatives As Alpha(1a)-Adrenoceptor Antagonists

Design, Synthesis and Biological Evaluation of New Arylpiperazine Derivatives Bearing a Flavone Moiety as α1-Adrenoceptor Antagonists.

Studies On Synthesis And Biological Activity Of Pyridazinone Derivatives As Alpha(1)-Adrenoceptor Antagonist

Pharmacophore-guided design, synthesis and evaluation of quinazoline-arylpiperazines as new ±1-adrenoceptor antagonists

Synthesis, Crystal Structure, Biological Evaluation, and Molecular Docking Studies of Quinoline-Arylpiperazine Derivative As Potent Α1a-Adrenoceptor Antagonist

Design, Synthesis, Crystal Structure, Biological Evaluation and Molecular Docking Studies of Carbazole-Arylpiperazine Derivatives.

Synthesis, structure-activity relationship and biological evaluation of novel arylpiperzines as α1A/1D-AR subselective antagonists for BPH.

Design, Synthesis and Biological Activities of Piperidine-Spirooxadiazole Derivatives As Α7 Nicotinic Receptor Antagonists

Structural Analysis of (S)-1-((1h-benzo[d][1,2,3]triazol-1-yl)oxy)-3-(4-(2-methoxyphenyl)piperazin-1-yl)propan-2-ol and Binding Mechanism with Α1a-Adrenoceptor: TDDFT Calculations, X-ray Crystallography and Molecular Docking

Synthesis and Biological Activity of Novel Imidazo[2,1-b] [1,3,4] thiadiazole Derivatives

Rational Design, Synthesis, Biologic Evaluation, and Structure–activity Relationship Studies of Novel 1‐indanone Α1‐adrenoceptor Antagonists

Synthesis and biological activity of carbamoyl substituted phenoxylalkylamine derivatives